A single-arm observational study to characterize the demographic, clinical features and outcomes of a Brazilian cohort of patients with lung cancer.

Trial Identifier:	D133FR00225
Sponsor:	AstraZeneca
Start Date:	May 2026
Primary Completion Date:	January 2027
Study Completion Date:	January 2027
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil, Rio de Janeiro	Rio de Janeiro, Brazil, 20230-130

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.